T1	Participants 514 645	12 autistic subjects completed a 10-week, double-blind, crossover comparison of clomipramine and placebo, and 12 different subjects
T2	Participants 746 845	A referral sample of 30 male and female autistic patients were enrolled, and 24 completed the study
